-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on Veracyte, Raises Price Target to $69

Benzinga·07/31/2026 09:46:30
Listen to the news
Needham analyst Mike Matson maintains Veracyte (NASDAQ:VCYT) with a Buy and raises the price target from $57 to $69.